J. Bruce McClain - Concepedia

Concepedia

Author

J. Bruce McClain

Also Known As

J B McClain, J Bruce McClain, J McClain, J. B. McClain, J. BRUCE L. McCLAIN, J. BRUCE MCCLAIN, J. BRUCE McCLAIN, J. Bruce McClain, J.B. McClain, J.Bruce McClain

49

Publications

3.2K

Citations

24

H-Index

53

Concepts

All Affiliations

Aeras South African Tuberculosis Vaccine Initiative University of Cape Town University of Oxford Jenner Institute

JB

About

J. Bruce McClain is an author at Aeras specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	2.1K
2	Health Sciences	2	2	84
3	Epidemiology	2	2	209
4	Public Health	1	1	140
5	Allergy	1	1	10

J. Bruce McClain

×

30

Publications

3.2K

Citations

24

H-Index

	Year	Citations
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial Michèle Tameris, Mark Hatherill, Bernard Landry, The Lancet VaccinationVaccine SafetyVaccinologyNew Tuberculosis VaccinePulmonary Tuberculosis	2013	1K
T-cell activation is an immune correlate of risk in BCG vaccinated infants Helen A. Fletcher, Margaret Ann Snowden, Bernard Landry, Nature Communications	2016	268
Doxycycline Therapy for Leptospirosis J. Bruce McClain Annals of Internal Medicine InflammationDoxycycline TherapyAntibioticsPharmacologyTherapeutic Efficacy	1984	232
The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 <sup>+</sup> and CD8 <sup>+</sup> T Cells in Adults Michèle Tameris, Nazma Mansoor, Sebastian Gelderbloem, American Journal of Respiratory and Critical Care Medicine	2010	227
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study Jason R. Andrews, Elisa Nemes, Michèle Tameris, The Lancet Respiratory Medicine Epidemiological TrendPulmonary TuberculosisSerial Quantiferon TestingTuberculosis Disease RiskPediatric Epidemiology	2017	140
Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa Infections Sam T. Donta, Peter Peduzzi, Alan S. Cross, The Journal of Infectious Diseases	1996	112
SAFETY AND EFFICACY OF HIGH-DOSE SODIUM STIBOGLUCONATE THERAPY OF AMERICAN CUTANEOUS LEISHMANIASIS W. Ripley Ballou, D M Gordon, Jose E. Andujar, The Lancet Translational MedicineAmerican Cutaneous LeishmaniasisParasitic ProtozoaPharmacologyTopical Drug	1987	108
A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity Daniel F. Hoft, Azra Blazevic, Jaime Stanley, Vaccine VaccinationImmunodominant Tb AntigensBcg-induced Human ImmunityVaccine TargetRecombinant Adenovirus	2012	92
Experimental Gonococcal Urethritis and Reinfection with Homologous Gonococci in Male Volunteers Katherine A. Schmidt, Herman Schneider, Jill A. Lindstrom, Sexually Transmitted Diseases	2001	86
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial Hennie Geldenhuys, Helen Mearns, David J. C. Miles, Vaccine VaccinationImmunologyVaccine TrialAutoimmunityT Cell Immunity	2015	79

Page 1